State of Wisconsin Investment Board’s Amylyx Pharmaceuticals AMLX Stock Holding History

State of Wisconsin Investment Board’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Sell	61,278 -10,783	-15%	-$167K	﹤0.01%	1734
2026 Q1	$1M	Sell	72,061 -12,083	-14%	-$170K	﹤0.01%	1689
2025 Q4	$1.02M	Buy	84,144 +70,269	+506%	+$954K	﹤0.01%	1673
2025 Q3	$189K	Buy	+13,875	New	+$131K	﹤0.01%	2268
2024 Q3	–	Sell	-138,500	Closed	-$263K	–	2289
2024 Q2	$263K	Sell	138,500 -223,222	-62%	-$433K	﹤0.01%	2068
2024 Q1	$1.03M	Buy	361,722 +333,268	+1,171%	+$4.36M	﹤0.01%	1422
2023 Q4	$419K	Buy	28,454 +2,759	+11%	+$42.3K	﹤0.01%	1856
2023 Q3	$470K	Sell	25,695 -6,378	-20%	-$135K	﹤0.01%	1816
2023 Q2	$692K	Buy	+32,073	New	+$866K	﹤0.01%	1644

Other funds holding AMLX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

State of Wisconsin Investment Board's AMLX Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its Amylyx Pharmaceuticals (AMLX) stake by 15% in Q2 2026, selling an estimated $167K and leaving 61,278 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1734.

State of Wisconsin Investment Board first reported a position in AMLX in Q2 2023 and has held it in 9 quarters since. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

State of Wisconsin Investment Board held 61,278 shares of Amylyx Pharmaceuticals worth $1.1M as of Q2 2026.
State of Wisconsin Investment Board sold 10,783 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $167K.
Amylyx Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1734 holding.
State of Wisconsin Investment Board first reported a position in Amylyx Pharmaceuticals in Q2 2023 and has held it in 9 quarters since.
206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.